Trial intelligence / Profile preview

Pregabalin for neuropathic pain after spinal cord injury (subacute phase)

2011-000915-14Phase 4Active

Sponsor
Julian Taylor
Start
Jun 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of pregabalin in Neuralgia and Spinal Cord Injury-Related Pain (SCI-Pain), sponsored by Julian Taylor. Primary endpoint: Primary: Daily non-evoked pain intensity at level of spinal cord injury. Started Jun 2011; status: active.

02

Drugs

pregabalin
03

Conditions

NeuralgiaSpinal Cord Injury-Related Pain (SCI-Pain)

Beyond the preview

Go deeper on 2011-000915-14.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-000915-14.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call